Aerosol-Generating Procedures and Virus Transmission
- PMID: 35387846
- DOI: 10.4187/respcare.10160
Aerosol-Generating Procedures and Virus Transmission
Abstract
During the early phase of the COVID-19 pandemic, many respiratory therapies were classified as aerosol-generating procedures. This categorization resulted in a broad range of clinical concerns and a shortage of essential medical resources for some patients. In the past 2 years, many studies have assessed the transmission risk posed by various respiratory care procedures. These studies are discussed in this narrative review, with recommendations for mitigating transmission risk based on the current evidence.
Copyright © 2022 by Daedalus Enterprises.
Conflict of interest statement
Dr Li discloses relationships with The Rice Foundation, American Association for Respiratory Care, Fisher & Paykel Healthcare, Aerogen, and Heyer. Dr Li also serves as section editor for Respiratory Care. Dr Fink is chief science officer for Aerogen Pharma Corp. Dr Dhand discloses relationships with GlaxoSmithKline, Boehringer Ingelheim, Mylan, Teva, and AstraZeneca. Ms Alolaiwat has disclosed no conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous